Our Partners 

The WFH is grateful for the generous financial contributions our partners have made to support the WFH vision of Treatment for All.

Patron

Jan-Willem André de la Porte


Corporate Partners

Bayer
BioMarin Pharmaceutical Inc
Biotest
CSL Behring
F. Hoffmann-La Roche Ltd
GC Pharma
Grifols
Kedrion
Novo Nordisk
Novo Nordisk Haemophilia Foundation
Octapharma
Pfizer
Precision BioLogic
Sangamo Therapeutics
Sanofi Genzyme
Spark Therapeutics
Sobi
Takeda
uniQure

 

For more information about the WFH Corporate Partner Program, please contact our Corporate Relations Manager at cpp@wfh.org.

For news on our corporate partners click here.


Community Partners

Hemophilia of Georgia, Inc.
The Hemophilia Alliance

 


Read press releases of interest to the global bleeding disorders community: